Akesion - One Solution

Of patients who undergo abdominal surgery, over 50% develop adverse adhesions between organs. Adhesions often lead to pain, infertility and, in severe cases, to life-threatening bowel obstruction. A new drug developed by the startup company Akesion removes the main precursor of these adhesions preventing the formation of adhesions as well as risky repeat surgeries that are stressful to patients.

More videos by this producer

1:01
3:46
2:25

Articles by this producer

This website uses cookies to ensure you get the best experience on our website. Learn more in our privacy policy.